WASHINGTON, D.C. (LifeSiteNews) — GOP leaders and pro-life advocates are pushing back against the Food and Drug Administration (FDA) after it approved a generic version of the abortion pill mifepristone, even while the drug is supposed to be under review. Less than a month after Health and Human Services Secretary Robert F. Kennedy Jr. announced that the FDA would review the dangers of abortion drugs, the agency approved the generic version of mifepristone.
Led by Senator Josh Hawley (R-MO) and Congressman Mark Harris (R-NC), lawmakers are calling for a review of the individuals responsible for this approval.
Rep. Mark Harris, along with 12 other members of Congress, sent a letter directly to Robert F. Kennedy Jr. on October 3. In their letter, Harris and his colleagues urged Kennedy to launch an investigation into “rogue actors” within the FDA who they say were responsible for the approval.
“It is clear that rogue actors within the FDA are working to undermine both the sanctity of life and the Administration’s commitment to protecting it,” wrote Harris.
“For this reason, we respectfully urge that you consider the director of the Office of Generic Drugs, the director of the Center for Drug Evaluation and Research, and other bureaucrats responsible for this reckless decision as part of your reduction-in-force evaluations.”
Sen. Hawley first issued a formal letter to the FDA commissioner, Marty Makary, on October 3. In his letter, Senator Hawley outlined the dangers of the pills, citing statistics such as 11 percent of women suffering adverse health effects. He then went on to scrutinize the FDA’s review process, labeling it as potentially “toothless.”
“FDA is supposed to be conducting a review of the safety regulations around mifepristone,” wrote Hawley.
“But because this new generic has been approved before any changes to those safety protocols, this drug may be exempted from any new safety standards imposed on mifepristone in the future.”
“That would render your safety review toothless and irrelevant,” stated Hawley.
Pro-life activist and Live Action founder Lila Rose immediately released a statement condemning the reckless approval of the abortion pill and called for quick action to be taken against the FDA.
“The FDA is not focused on American healthcare and blatantly disregards the safety of women and children,” stated Lila Rose.
“FDA Commissioner Marty Makary and HHS Secretary Kennedy Jr. must reverse this decision immediately, for the safety of our nation’s women and children.”
